Skin Molecules Promote Cutaneous Lupus
June 24, 2019
Patients with cutaneous lupus develop rashes because immune cells move into the skin and cause inflammation. With...
TIL
New Study Partly Funded by LRA Reveals Novel Lupus Drug Targets
NEW YORK, NY – May 29. Researchers partly funded by the Lupus Research Alliance (LRA) have found possible new...
Celebrate Clinical Trials Day May 20!
May 20, 2019
It’s Clinical Trials Day when the Lupus Research Alliance recognizes all the people we support who advance...
New Approach to Treating Lupus Nephritis
February 6, 2019
Scientists partly funded by the Lupus Research Alliance have found a potential new way to protect the...
Potential New Lupus Treatment Outperforms Hydroxychloroquine in Animal Study
November 28, 2018
Anti-malaria drugs such as hydroxychloroquine are common treatments for arthritis and heat rash in patients with lupus....
Potential Treatment for Sun Damage Discovered with LRA Funding
August 16, 2018
Exposure to the sun is hard on everyone’s skin, causing cells to die. But skin cells are...
2017-18 Research Portfolio Summary
June 5, 2018
The Lupus Research Alliance is driven by one central goal — to improve the lives of people living...
Lupus Research Alliance Announces New Grants For Translational Research
Jan. 10, 2018
Lupus Research Alliance Announces New Grants for Translational Research
Seven Outstanding Investigators Chosen for Prestigious Lupus Research Grants
The...
New TIL Grantees Offer Novel Approaches
Sept. 7, 2017. Grantees of our Target Identification in Lupus (TIL) program are remarkable scientific investigators whose ingenuity and...
Microchip Technology Charts New Ground
Sept. 7, 2017. The study of T cells and B cells, their function, and the interaction between them that...